NCT03368586

Brief Summary

The aim of this study was to assess accuracy, satisfaction and usability of the FGM among children and adolescents with T1DM. The primary outcome was to assess the accuracy of the FGM system. Secondary outcomes included satisfaction and usability of the device as well as assessment of sensor-related issues.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 2, 2016

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 24, 2017

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 11, 2017

Completed
Last Updated

December 11, 2017

Status Verified

December 1, 2017

Enrollment Period

28 days

First QC Date

November 24, 2017

Last Update Submit

December 8, 2017

Conditions

Keywords

Flash Glucose MonitoringChildrenAdolescents

Outcome Measures

Primary Outcomes (1)

  • FGM accuracy

    Accuracy of FGM values versus reference blood glucose values (Consensus Error Grid (CEG) analysis and calculation of the Mean Absolute Relative Difference (MARD))

    through study completion, 1 week

Secondary Outcomes (3)

  • Participants satisfaction with the FGM system

    At last camp day

  • Caregivers satisfaction with the FGM system

    At last camp day

  • Sensor related-issues

    Through study completion, 1 week

Interventions

The camp comprised a structured daily routine with five fixed meals: breakfast, lunch, afternoon snack, dinner and evening snack. Capillary blood glucose (BG) values were measured in parallel with unmasked Flash Glucose (FG) measurements using the FGM reader's built-in glucometer at breakfast, lunch and dinner. Additional measurements were taken before snacks, between the meals or overnight and BG was measured only in cases of low (\<4.0 mmol/L) or high (\>15.0 mmol/L) FG values or when symptoms were discordant with sensor readings. Sensor-related issues were documented and a questionnaire assessing satisfaction and usability of the FGM was completed by patients and caregivers at study completion.

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children and adolescents, aged 6-18 years old, with type 1 diabetes mellitus, participating at the diabetes summer camp.

You may qualify if:

  • Type 1 diabetes mellitus, children and adolescents participating at the diabetes summer camp.

You may not qualify if:

  • Acute health condition (infectious disease), known allergy to medical adhesives or with a skin condition (e.g. atopic dermatitis)).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Michael Hauschild, MD

    Lausanne University Hospitals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

November 24, 2017

First Posted

December 11, 2017

Study Start

July 2, 2016

Primary Completion

July 30, 2016

Study Completion

July 30, 2017

Last Updated

December 11, 2017

Record last verified: 2017-12

Data Sharing

IPD Sharing
Will share

The study protocol and informed consent form will be publicly available. Individual participant data (IPD) collected in this study, including participants individual data, cannot be shared.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
study end
Access Criteria
not yet defined